KATIE CALLIS: Open Payments
NPI 1639736770 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 3 payments from 3 companies in 2025. Trend: 2023 $515 · 2024 $1,151 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Tris Pharma Inc | 1 | $110 |
| Neurocrine BioSciences, Inc. | 1 | $96 |
Products named: FASENRA, Dyanavel XR, INGREZZA.
Industry payments across MO — which companies pay providers there.
